Matsumoto Yushi-Seiyaku (4365) Q3 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2025 earnings summary
22 Jul, 2026Executive summary
Revenue for the nine months ended December 31, 2024, increased 3.8% year-over-year to ¥33,198 million, with operating profit up 9.6% to ¥7,486 million and net income attributable to shareholders up 4.8% to ¥5,932 million.
The Japanese segment saw strong growth, while the Asian segment experienced declines in both sales and profit.
Financial highlights
Gross profit rose to ¥10,866 million from ¥9,985 million year-over-year.
Operating profit increased to ¥7,486 million, and ordinary profit reached ¥8,412 million, both up from the previous year.
Net income per share for the period was ¥2,044.81, up from ¥1,950.15 in the prior year.
Comprehensive income decreased 10.4% year-over-year to ¥6,596 million.
Outlook and guidance
Full-year revenue is forecast at ¥41,300 million, a slight decrease of 0.5% year-over-year.
Operating profit is projected at ¥8,500 million (up 3.0%), and net income at ¥5,500 million (up 26.7%).
No changes have been made to previously announced guidance despite current results exceeding forecasts.
Latest events from Matsumoto Yushi-Seiyaku
- Q1 FY2027 delivered robust revenue and profit growth, with upwardly revised full-year guidance.4365
Q1 2027 - Strong Q1 growth in revenue and profit, with stable outlook and revised full-year guidance.4365
Q1 2025 - Revenue and operating profit rose, but net income fell; full-year outlook unchanged.4365
Q2 2025 - Q1 FY2026 profit dropped sharply, but full-year outlook anticipates a rebound.4365
Q1 2026 - Revenue up, net profit down; next year’s outlook undecided amid market uncertainty.4365
Q4 2025 - Revenue and operating profit fell, but net income rose; full-year outlook remains positive.4365
Q2 2026 - Revenue and profits fell, but guidance and dividend policy remain unchanged amid global risks.4365
Q3 2026 - Net income rose 17.7% despite lower sales, but outlook remains uncertain with no guidance.4365
Q4 2026